We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Highlights Range of Automatic Diagnostic Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022
Print article
Image: The compact, fully automated RX Monaco comprises an extensive test menu (Photo courtesy of Randox)
Image: The compact, fully automated RX Monaco comprises an extensive test menu (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is highlighting its extensive range of diagnostic analyzers at this year's MEDICA, the world's largest annual medical technology trade fair taking place from 14-17 November in Düsseldorf, Germany.

Among its innovative products being presented by Randox at MEDICA 2022 is the RX misano, a high performance semi-automated clinical chemistry analyzer. The RX misano shines a new light on semi-automated clinical chemistry testing with increased auto-functionality and groundbreaking technology and is capable of high standard, precise results at a competitive price per test. It expands testing capabilities with the ability to run both routine and specialized tests including chemistries, specific proteins, antioxidants, veterinary and diabetes testing, and can analyze a variety of sample types, including serum, plasma, and urine.

Randox is also exhibiting the RX monaco which comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes and veterinary testing with emergency and STAT sampling. The RX monaco is ideal for low to mid volume clinical chemistry testing consolidating routine and specialized testing on one efficient and easy to use platform. Offering the ultimate in convenience, performance and confidence, the RX monaco is capable of performing 170 photometric tests per hour. The RX monaco combines robust hardware and intuitive software offering customers choice to suit their unique circumstances, where they can choose between a benchtop or floor standing system.

Also on display at the Randox booth at MEDICA 2022 is the RX daytona+ fully automated analyzer which can perform a wide range of niche and specialized routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, diabetes and veterinary testing. The RX daytona+ also has direct HbA1c testing capabilities, eliminating sample pre-dilution and ultimately saving time in the laboratory, and can analyze a variety of sample types including serum, plasma urine, CSF and whole blood. The fully automated, random access platform can deliver a high level of precision, accuracy and reliability with the ability to perform emergency STAT sampling. The most versatile analyzer in its class, the RX daytona+ is capable of performing 270 photometric tests per hour and up to 450 tests per hour with ISE.

Related Links:
Randox Laboratories

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.